识别可从暴露前预防获益的孕产妇风险评分工具
基于肯尼亚孕期及产后女性HIV前瞻性队列数据,随机分为推导队列(n=654)与验证队列(n=650),用多因素Cox模型建立风险评分。最终评分含伴侣HIV状态不明、终生性伴数、梅毒、细菌性阴道病和阴道念珠菌病,推导队列AUC为0.84(95%CI .72-.95)。简化评分(去除BV和念珠菌病)AUC为0.76(95%CI .67-.85),评分>6者HIV发病率为7.3/100人年,高于≤6者的1.1/100人年(P<.001)。
要点
- 产前常规可获指标组成的风险评分能预测孕产妇HIV感染风险。
- 简化评分>6者占人群16%却占HIV感染56%,可用于优先安排PrEP。
- 最终评分每增加1分,HIV风险增加52%(HR 1.52,95%CI 1.32-1.76)。
核心结论
- 产前门诊常规评估指标组合可预测孕产妇HIV感染风险,并用于确定PrEP优先人群。
研究设计与样本
- 肯尼亚孕期及产后女性HIV前瞻性队列研究,随机分为推导队列(n=654)与验证队列(n=650),采用多因素Cox比例风险模型和标准临床预测规则建立风险评分。
主要发现
- 最终风险评分包含伴侣HIV状态不明、终生性伴数、梅毒、细菌性阴道病和阴道念珠菌病。
- 推导队列AUC为0.84(95%CI .72-.95),Brier评分为0.11,每增加1分HIV风险增加52%(HR 1.52,95%CI 1.32-1.76;P<.001)。
- 验证队列AUC、Brier评分和估计HR与推导队列相似。
- 简化评分(去除BV和念珠菌病)AUC为0.76(95%CI .67-.85)。
- 简化评分>6者HIV发病率为7.3/100人年,≤6者为1.1/100人年(P<.001);>6者占人群16%但占HIV感染56%。
关键数值与推荐
- 最终评分预测HIV感染的AUC为0.84(95%CI .72-.95),简化评分AUC为0.76(95%CI .67-.85)。
- 最终评分每增加1分,HIV风险HR为1.52(95%CI 1.32-1.76;P<.001)。
- 简化评分>6者HIV发病率为7.3/100人年,≤6者为1.1/100人年(P<.001)。
临床怎么用
- 可在产前门诊用常规可获指标计算风险评分,优先为高分孕产妇提供PrEP咨询与干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A human immunodeficiency virus (HIV) risk assessment tool for pregnant women could identify women who would most benefit from preexposure prophylaxis (PrEP) while minimizing unnecessary PrEP exposure. METHODS: Data from a prospective study of incident HIV among pregnant/postpartum women in Kenya were randomly divided into derivation (n = 654) and validation (n = 650) cohorts. A risk score was derived using multivariate Cox proportional hazards models and standard clinical prediction rules. Ability of the tool to predict maternal HIV acquisition was assessed using the area under the curve (AUC) and Brier score. RESULTS: The final risk score included the following predictors: having a male partner with unknown HIV status, number of lifetime sexual partners, syphilis, bacterial vaginosis (BV), and vaginal candidiasis. In the derivation cohort, AUC was 0.84 (95% confidence interval [CI], .72-.95) and each point increment in score was associated with a 52% (hazard ratio [HR], 1.52 [95% CI, 1.32-1.76]; P < .001) increase in HIV risk; the Brier score was 0.11. In the validation cohort, the score had similar AUC, Brier score, and estimated HRs. A simplified score that excluded BV and candidiasis yielded an AUC of 0.76 (95% CI, .67-.85); HIV incidence was higher among women with risk scores >6 than with scores ≤6 (7.3 vs 1.1 per 100 person-years, respectively; P < .001). Women with simplified scores >6 accounted for 16% of the population but 56% of HIV acquisitions. CONCLUSIONS: A combination of indicators routinely assessed in antenatal clinics was predictive of HIV risk and could be used to prioritize pregnant women for PrEP.
引用
- Pintye J, Drake AL, Kinuthia J, et al. A Risk Assessment Tool for Identifying Pregnant and Postpartum Women Who May Benefit From Preexposure Prophylaxis. Clin Infect Dis. 2017. PMID: 28034882. doi:10.1093/cid/ciw850
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。